How Cell and Gene Manufacturers Can Scale to Meet Demand

December 21, 2022
Cara Schildmeyer

Between 2022 and 2030, the cell and gene therapy sector is expected to experience a compound annual growth rate (CAGR) of 39.42 percent, BioSpace said of a recent Vision Research Report.

This is quite a large anticipated growth; how will startups and current manufacturing companies work to meet this growing demand?

On today’s episode of Exceeding Your Benchmark, Host Sumit Verma, Senior Vice President, Global Strategic Manufacturing at Iovance Biotherapeutics, addresses cell and gene therapy industry trends and challenges and what manufacturers can do to promote growth in the sector.

Verma also discussed…

  1. The greatest challenges biopharma startups face
  2. How established CGT manufacturers are preparing to meet an increased demand
  3. What place automation has in advanced cell manufacturing

Verma believes there are three key areas manufacturers need to target to help supply meet increasing demand. “I think most players are focusing on three big things: one is around scalability, the second is around supply chain, making sure we have all the components, and last is about talent. Verma said of the talent piece, “There aren’t many people who have advanced programs for therapeutic manufacturing today…there are a lot of synergies and the big pharma have done a great job establishing developing programs that are very supportive of their large plants and their scalable efforts and we’ve seen the need to do that in cell and gene therapy.

Recent Episodes

four perspectives in 2024
View episode

In a dynamic exchange on the Amend & Progress podcast by Vodori, Annalise Ludtke explores four perspectives in 2024 that will help bring effective content to the market now and beyond. With the participation of Vodori’s CEO and Co-Founder, Scott Rovegno, the conversation unveils insights on macro-level topics crucial to the organization’s strategic direction. […]

modern digital laboratory
View episode

As the healthcare industry navigates through its ongoing technological revolution, the focus sharpens on the role of the modern digital laboratory. This evolution from traditional methodologies to digital platforms in pathology labs marks a pivotal advancement, especially in cancer diagnosis and treatment. Highlighted by the FDA’s 2017 approval of the first diagnostic scanner for […]

Data privacy in healthcare
View episode

In today’s rapidly evolving digital landscape, healthcare data is becoming increasingly vital. However, navigating the complexities of HIPAA compliance and data privacy in healthcare poses a significant challenge for medical and technology professionals. In this context, Shubh Sinha, CEO of Integral, is leading the charge in transforming how sensitive data is handled, ensuring both […]